Enhancement of cisplatin cytotoxicity by benzyl isothiocyanate in HL-60 cells

Food and Chemical Toxicology

Volumn 50, Issue 7, 2012, Pages 2397-2406

  Lee, Younghyun ^a   Kim, Yang Jee ^b   Choi, Young Joo ^a   Lee, Joong Won ^a   Lee, Sunyeong ^a   Chung, Hai Won ^a  

^a Seoul National University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Apoptosis; Benzyl isothiocyanate; Cisplatin; Extracellular signal regulated kinase; Glutathione; Reactive oxygen species

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCYSTEINE; BENZYL ISOTHIOCYANATE; CISPLATIN; GLUTATHIONE; GLUTATHIONE ETHYL ESTER; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; GENE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LEUKEMIA CELL LINE; MEK 1 GENE; NORMAL HUMAN; PROMYELOCYTIC LEUKEMIA; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CISPLATIN; DNA PRIMERS; DRUG SYNERGISM; HL-60 CELLS; HUMANS; ISOTHIOCYANATES; REAL-TIME POLYMERASE CHAIN REACTION;

CARICA PAPAYA;

EID: 84861433397     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.04.014     Document Type: Article

References (42)

1. Cagnol S., Chambard J.C. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J. 2010, 277:2-21.
2. Cnubben N.H., Rietjens I.M., Wortelboer H., van Zanden J., van Bladeren P.J. The interplay of glutathione-related processes in antioxidant defense. Environ. Toxicol. Pharmacol. 2001, 10:141-152.
3. Di Pasqua A.J., Hong C., Wu M.Y., McCracken E., Wang X., Mi L., Chung F.L. Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates. Chem. Res. Toxicol. 2010, 23:1307-1309.
4. Fimognari C., Nusse M., Lenzi M., Sciuscio D., Cantelli-Forti G., Hrelia P. Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations. Mutat. Res. 2006, 601:92-101.
5. Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., Kroemer, G., 2011. Molecular mechanisms of cisplatin resistance. Oncogene. Advance online publication, http://dx.doi.org/10.1038/onc.2011.384.
6. Godwin A.K., Meister A., O'Dwyer P.J., Huang C.S., Hamilton T.C., Anderson M.E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA 1992, 89:3070-3074.
7. Goldoni M., Johansson C. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model. Toxicol. In Vitro 2007, 21:759-769.
8. Higdon J.V., Delage B., Williams D.E., Dashwood R.H. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol. Res. 2007, 55:224-236.
9. Hileman E.O., Liu J., Albitar M., Keating M.J., Huang P. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother. Pharmacol. 2004, 53:209-219.
10. Hu K., Morris M.E. Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport. J. Pharm. Sci. 2004, 93:1901-1911.
11. Jakubikova J., Sedlak J., Bod'o J., Bao Y. Effect of isothiocyanates on nuclear accumulation of NF-kappaB, Nrf2, and thioredoxin in caco-2 cells. J. Agric. Food Chem. 2006, 54:1656-1662.
12. Kanellou P., Zaravinos A., Zioga M., Stratigos A., Baritaki S., Soufla G., Zoras O., Spandidos D.A. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14 (ARF), p15 (INK4b), p16 (INK4a) and p53 in actinic keratosis. Cancer Lett. 2008, 264:145-161.
13. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 2007, 7:573-584.
14. Kundu J.K., Surh Y.J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269:243-261.
15. Lee J.J., Kong M., Ayers G.D., Lotan R. Interaction index and different methods for determining drug interaction in combination therapy. J. Biopharm. Stat. 2007, 17:461-480.
16. Lee W.J., Lee M.H., Su N.W. Characteristics of papaya seed oils obtained by extrusion-expelling processes. J. Sci. Food Agric. 2011, 91:2348-2354.
17. Lee Y.K., Hwang J.T., Kwon D.Y., Surh Y.J., Park O.J. Induction of apoptosis by quercetin is mediated through AMPKalpha1/ASK1/p38 pathway. Cancer Lett. 2010, 292:228-236.
18. Lu Y., Cederbaum A. The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2cells: Modulation by ERK, ROS, glutathione, and thioredoxin. Free Radic. Biol. Med. 2007, 43:1061-1075.
19. M'Bemba-Meka P., Lemieux N., Chakrabarti S.K. Role of oxidative stress, mitochondrial membrane potential, and calcium homeostasis in nickel sulfate-induced human lymphocyte death in vitro. Chem. Biol. Interact. 2005, 156:69-80.
20. McCubrey J.A., Lahair M.M., Franklin R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal 2006, 8:1775-1789.
21. Meijer C., Mulder N.H., Hospers G.A., Uges D.R., de Vries E.G. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br. J. Cancer 1990, 62:72-77.
22. Mistry P., Kelland L.R., Abel G., Sidhar S., Harrap K.R. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br. J. Cancer 1991, 64:215-220.
23. Miyoshi N., Uchida K., Osawa T., Nakamura Y. A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Res. 2004, 64:2134-2142.
24. Nachshon-Kedmi M., Yannai S., Haj A., Fares F.A. Indole-3-carbinol and 3, 3'-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem. Toxicol. 2003, 41:745-752.
25. Nakamura Y., Kawakami M., Yoshihiro A., Miyoshi N., Ohigashi H., Kawai K., Osawa T., Uchida K. Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis. J. Biol. Chem. 2002, 277:8492-8499.
26. Nakamura Y., Yoshimoto M., Murata Y., Shimoishi Y., Asai Y., Park E.Y., Sato K. Papaya seed represents a rich source of biologically active isothiocyanate. J. Agric. Food Chem. 2007, 55:4407-4413.
27. Pan J.S., Hong M.Z., Ren J.L. Reactive oxygen species: a double-edged sword in oncogenesis. World J. Gastroenterol. 2009, 15:1702-1707.
28. Perez R.P., Hamilton T.C., Ozols R.F., Young R.C. Mechanisms and modulation of resistance to chemotherapy in ovarian cancer. Cancer 1993, 71:1571-1580.
29. Sahu R.P., Zhang R., Batra S., Shi Y., Srivastava S.K. Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells. Carcinogenesis 2009, 30:1744-1753.
30. Schramek H., Sorokin A., Watson R.D., Dunn M.J. ET-1 and PDGF BB induce MEK mRNA and protein expression in mesangial cells. J. Cardiovasc. Pharmacol. 1995, 26(Suppl. 3):S95-S99.
31. Schweyer S., Soruri A., Heintze A., Radzun H.J., Fayyazi A. The role of reactive oxygen species in cisplatin-induced apoptosis in human malignant testicular germ cell lines. Int. J. Oncol. 2004, 25:1671-1676.
32. Schweyer S., Soruri A., Meschter O., Heintze A., Zschunke F., Miosge N., Thelen P., Schlott T., Radzun H.J., Fayyazi A. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br. J. Cancer 2004, 91:589-598.
33. Shiu L.Y., Chang L.C., Liang C.H., Huang Y.S., Sheu H.M., Kuo K.W. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. Food Chem. Toxicol. 2007, 45:2155-2164.
34. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003, 22:7265-7279.
35. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug Discovery 2009, 8:579-591.
36. Troncoso R., Espinoza C., Sanchez-Estrada A., Tiznado M.E., Garcia H.S. Analysis of the isothiocyanates present in cabbage leaves extract and their potential application to control alternaria rot in bell peppers. Food Res. Int. 2005, 38:701-708.
37. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biol. Med. 1999, 27:612-616.
38. Wang X., Govind S., Sajankila S.P., Mi L., Roy R., Chung F.L. Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol. Nutr. Food Res. 2011, 55:1572-1581.
39. Wang X., Martindale J.L., Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 2000, 275:39435-39443.
40. Woo C.H., You H.J., Cho S.H., Eom Y.W., Chun J.S., Yoo Y.J., Kim J.H. Leukotriene B (4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J. Biol. Chem. 2002, 277:8572-8578.
41. Wozniak K., Czechowska A., Blasiak J. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571. Chem. Biol. Interact. 2004, 147:309-318.
42. Yeh P.Y., Yeh K.H., Chuang S.E., Song Y.C., Cheng A.L. Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation. J. Biol. Chem. 2004, 279:26143-26148.